Accelerating Biopharma Manufacturing Through Integrated Automation
Biopharmaceutical manufacturers are facing mounting pressure to scale production faster while maintaining quality and operational reliability due to the ever-expanding pipeline of therapies. Meanwhile...
30 Kesä 21min
The Future of Global Biopharma Manufacturing Networks
Amid ongoing geopolitical uncertainty, regional manufacturing initiatives, and evolving supply chain risks reshaping the pharmaceutical industry, manufacturers are rethinking how biologics are produce...
23 Kesä 12min
Building Flexibility into Biopharma Manufacturing
As biopharma pipelines become more complex and market conditions continue to evolve, manufacturers are rethinking how they scale capacity, deploy capital, and build supply chains. The industry’s focus...
16 Kesä 19min
How Biocatalysis Is Changing Pharma Manufacturing
Interest in macrocyclic peptides (MCPs) continues to grow, which means manufacturers are facing mounting pressure to develop production methods capable of supporting commercial-scale demand of these m...
9 Kesä 19min
How Peptide Development Complexity Is Reshaping CDMO Partnerships: Part Two
As peptide therapeutics become larger, more complex, and increasingly purity-sensitive, manufacturers are confronting a new layer of execution challenges. Long-chain peptides introduce compounding sca...
2 Kesä 20min
How Peptide Development Complexity Is Reshaping CDMO Partnerships: Part One
Peptide pipelines continue to expand globally, and pharmaceutical companies are increasingly turning to CDMOs earlier in the development lifecycle to help manage growing technical and operational comp...
26 Touko 20min
Solutions Spotlight: Managing Chloramines in Pharmaceutical Water Systems
As municipal water utilities increasingly shift from free chlorine to chloramine disinfection strategies, pharmaceutical manufacturers are facing new challenges in maintaining consistent, high-purity ...
22 Touko 17min
Can CDMO-to-CDMO Collaboration Simplify Drug Development?
Amid increasing complexity in the drug development landscape, CDMOs are exploring new ways to streamline the path from early-stage formulation through commercial manufacturing. Rather than operating i...
19 Touko 19min
